UDISIGN 300 Tablet by Dr Precision (BluepillExpress) contains 300 mg of Ursodeoxycholic Acid (UDCA), a potent hepatoprotective agent specifically formulated for effective liver care. This micronized UDCA formulation enhances bioavailability to treat various cholestatic liver diseases, primary biliary cirrhosis, and gallstones by improving bile flow and reducing toxic bile acids. Manufactured under stringent WHO-GMP and Schedule M compliant conditions, UDISIGN 300 ensures superior purity, consistent quality, and stability. Ideal for hospitals, clinics, and pharmaceutical distributors, it offers versatile packaging, including blister and alu-alu strips, along with customizable branding and comprehensive export documentation. This product is especially suited for long-term management of liver disorders requiring sustained UDCA therapy with proven efficacy and safety evaluations backed by advanced analytical testing.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Ursodeoxycholic Acid (UDCA) 300 mg per tablet |
| Indications | Primary biliary cholangitis, cholestatic liver diseases, gallstone dissolution, NAFLD, cystic fibrosis-related liver disorders |
| Formulation | Micronized UDCA for enhanced absorption and bioavailability |
| Manufacturing Standards | WHO-GMP, ISO 9001:2015, Schedule M certified production facility |
| Packaging Options | 10x10 tablets blister or alu-alu packs; bulk strip packaging available; customizable branding for exports |
| Quality Assurance | HPLC purity assay, microbiological screening, stability profiling, dissolution & disintegration testing |
| Dosage Form | Oral tablets |
| Shelf Stability | Maintains potency under tropical storage conditions |
| Special Features | Tamper-proof packaging ensures product integrity |
| Regulatory Support | Provides CTD/eCTD dossiers, COA, Stability Data, COPP for regulatory submissions |
| Attributes | Description |
|---|---|
| Composition | Ursodeoxycholic Acid IP – 300 mg, Excipients – q.s. |
| Dosage Recommendation | 8–15 mg/kg/day divided into 2–3 doses |
| Treatment Duration | 6-12 months for gallstones; long-term for chronic cholestatic disorders |
| Packaging Type | Blister or alu-alu packs; bulk strips |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Branding Options | Available for third-party branding with multilingual export labels |
| Quality Tests Conducted | HPLC assay, microbiological screening, stability testing, dissolution & disintegration |
| Common Side Effects | Mild diarrhea, nausea, abdominal discomfort, rare allergic reactions |
| Cautions | Not suitable for calcified gallstones or obstructed bile ducts; monitor liver enzyme levels during therapy |
| Manufacturer | BluepillExpress under Dr Precision label |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
The micronized UDCA particles in UDISIGN 300 enhance solubility and absorption in the gastrointestinal tract, resulting in better bioavailability and faster therapeutic action for liver disease management.
Each batch undergoes HPLC assay for purity confirmation, microbiological screening, stability profiling, and dissolution testing to ensure that UDISIGN 300 maintains high quality and consistent efficacy.
Yes, BluepillExpress offers customizable packaging with multilingual labels and branding options as well as necessary regulatory dossiers such as CTD/eCTD and COA to facilitate international distribution.
UDISIGN 300 tablets demonstrate excellent shelf stability under tropical conditions but should still be stored in a cool, dry place away from direct sunlight to maintain potency.
No, UDISIGN 300 is not effective for calcified gallstones or patients with obstructed bile ducts, and alternative treatment approaches should be considered.
UDISIGN 300 is manufactured in WHO-GMP, ISO 9001:2015, and Schedule M certified facilities, ensuring compliance with global quality and safety standards.
UDISIGN 300 modulates the immune response against bile duct cells in autoimmune liver diseases like primary biliary cholangitis, reducing liver inflammation and progression.
Country Of Origin: India
UDISIGN 300 Tablet, a flagship liver care product by BluepillExpress, features Ursodeoxycholic Acid (UDCA) 300 mg. It is an orally administered hepatoprotective agent widely used for the treatment of cholestatic liver diseases, gallstones, and primary biliary cirrhosis. UDCA is a naturally occurring bile acid that improves bile flow and reduces liver enzyme levels, thereby aiding liver regeneration and slowing disease progression.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
UDISIGN 300 Tablet, a flagship liver care product by BluepillExpress, features Ursodeoxycholic Acid (UDCA) 300 mg. It is an orally administered hepatoprotective agent widely used for the treatment of cholestatic liver diseases, gallstones, and primary biliary cirrhosis. UDCA is a naturally occurring bile acid that improves bile flow and reduces liver enzyme levels, thereby aiding liver regeneration and slowing disease progression.
Manufacturing Excellence by BluepillExpress
At BluepillExpress, UDISIGN 300 is produced in WHO-GMP, ISO 9001:2015, and Schedule M certified units. We ensure:
Precision formulation with micronized UDCA for optimal bioavailability
High-shear granulation technology for consistent particle dispersion
Tamper-proof blister or alu-alu packaging to preserve product integrity
Each batch undergoes:
HPLC assay for purity confirmation
Microbiological screening
Stability profiling
Dissolution and disintegration testing
Composition:
Ursodeoxycholic Acid IP – 300 mg
Excipients – q.s.
Indications:
UDISIGN 300 Tablet is indicated for:
Primary Biliary Cholangitis (PBC)
Non-alcoholic fatty liver disease (NAFLD)
Cholestatic liver diseases
Gallstone dissolution (especially in patients unsuitable for surgery)
Cystic fibrosis-related liver disorder
Chronic liver diseases of cholestatic origin
Mechanism of Action:
Ursodeoxycholic Acid works through multiple hepatoprotective mechanisms:
Reduces the cholesterol saturation of bile, aiding dissolution of gallstones
Protects liver cells from toxic bile acids
Stimulates bile flow, reducing cholestasis
Modulates immune response in autoimmune liver disease
Dosage & Administration:
Recommended dosage: 8–15 mg/kg/day, divided into 2–3 doses.
For gallstone treatment: Administer 300–600 mg/day in divided doses for 6–12 months.
For chronic cholestatic disorders: Long-term therapy (under physician supervision).
Packaging Options:
10 x 10 Tablets per box in blister/alu-alu packs
Customized export packaging with multilingual labels
Bulk strip packaging for hospital or institutional use
Customizable branding under your label
BluepillExpress also offers CTD/eCTD dossiers, COA, Stability Data, and COPP for international regulatory submission.
Advantages of UDISIGN 300 by BluepillExpress:
Micronized formulation ensures faster absorption
Produced in fully automated and validated facilities
Excellent shelf stability under tropical conditions
Ready for third-party branding and international distribution
Precautions:
Regular monitoring of liver enzymes and bilirubin levels recommended
Caution in pregnancy and lactation
Not effective for calcified gallstones or obstructed bile ducts
Avoid alcohol and hepatotoxic medications during treatment
Side Effects:
Mild diarrhea or loose stools
Nausea or abdominal discomfort
Transient elevation in liver enzymes
Rare: Pruritus or allergic rash
Why Choose BluepillExpress for UDISIGN 300?
Decade-long expertise in hepatology-focused formulations
WHO-GMP certified third-party manufacturing services
Product customization for branding, dosage strength, and packaging
On-time global delivery with complete export documentation
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
